Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: Neuroblastoma

Cancer Immunology Immunotherapy

Volumn 42, Issue 3, 1996, Pages 170-178

  Facchetti, Paola ^a   Prigione, Ignazia ^a   Ghiotto, Fabio ^a   Tasso, Paola ^a   Garaventa, Alberto ^a   Pistoia, Vito ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

cytokines; cytotoxicity; neuroblastoma; T cell receptor; TIL

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CLONE CELLS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INFANT; INTERLEUKIN-2; LYMPHOCYTES, TUMOR-INFILTRATING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS;

EID: 0029929997     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050267     Document Type: Article

References (51)

1. Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sunders M, Lotze M, Topalian S, Yang J, Rosenberg SA (1991) Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J Natl Cancer Inst 83:932
2. Anichini A, Mazzocchi A, Fossati G, Parmiani G (1989) Cytotoxic T lymphocyte clones from peripheral blood and from tumour site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. J Immunol 142:3692
3. Anichini A, Maccalli C, Mortarini R, Salvi S, Mazzocchi A, Squarcina P, Herlyn M, Parmiani G (1993) Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med 177:989
4. Bakker ABH, Schreurs WJ, Boer AJ de, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179:1005
5. Brichard V, Van Pel A, Wolfel T, Wolfel C, DePlaen E, Lethè B, Coulie P, Boon T (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178:489
6. + monoclonal T cells and macrophages results in killing of trophozoites. J Immunol 140:3580
7. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989) Interaction of Staphylococcus aureus toxin "super-antigen" with human T cells. Proc Natl Acad Sci USA 86:8941
8. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156
9. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1a, interleukin-8 and RANTES. Eur J Immunol 25:751
10. Cozzolino F, Torcia M, Carossino AM, Giordani R, Selli C, Talini C, Reali E, Novelli A, Pistoia V, Ferrarini M (1987) Characterization of the cells from invaded lymph nodes in patients with solid tumours. Lymphokine requirement for a tumor-specific lymphoproliferative response. J Exp Med 166:303
11. Dalmau J, Graus F, Cheung NKV, Rosenblum MK, Ho A, Canete A, Delattre JY, Thompson SJ, Posner JB (1995) Major histocmpatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75:99
12. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Maechia D, Falagiani P, Ricci M, Romagnani S (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposing (type I T helper and type II T helper) profiles of cytokine production. J Clin Invest 8:346
13. Del Prete GF, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen specific proliferation and cytokine production. J Immunol 150:353
14. Fisher B, Packard BS, Read EJ, Carrasquillo JA, Carter CS, Topalian SL, Yang JC, Yolles P, Larson P (1989) Tumor lacalization of adoptively transferred indium-111 labeled tumor-infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 7:250
15. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern P (1993) Natural history of HLA expression during tumour development. Immunol Today 14:491
16. Gaugler B, Van den Eynde B, Van der Bruggen P, Romero P, Gafforio JJ, DePlaen E, Lethè B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921
17. Gillis SM, Ferm MM, Ou W, Smith KA (1978) T cell growth factor: parameters of production and quantitative microassay for activity. J Immunol 120:2027
18. Griffith KD, Read EJ, Carrasquillo JA, Carter CS, Yang JC, Fisher B, Aebersold P, Packard BS, Yu MY, Rosenberg SA (1989) In vivo distribution of adoptively transferred indium-111 labeled tumor-infiltrating lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst 81:1709
19. Haanen JBAG, De Waal Malefijt R, Res PCM, Kraakman EM, Ottenhoff THM, De Vries RRP, Spits H (1991) Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 174:583
20. Itoh K, Platsoucas CD, Balch CM (1988) Autologous tumor-specific cytototoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumour cells, and involvement of the T cell receptor. J Exp Med 168:1419
21. Kataoka Y, Matsumura T, Yamamoto S, Sugimoto T, Sawada T (1993) Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma. Cancer Lett 73:11
22. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Jannelli JR, Appella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumour infiltrating lymphocytes. J Exp Med 180:347
23. Lampson LA, Fisher CA, Whelan JP (1983) Striking paucity of HLA-A, B, C. and b2-microglobulin on human neuroblastoma cell lines. J Immunol 130:2471
24. Lauder I, Aherne W (1972) The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer 26:321
25. Leimig T, Foreman N, Rill D, Coze C, Holladay M, Brenner M (1994) Immunomodulatory effect of human neuroblastoma cells transduced with a retroviral vector encoding interleukin-2. Cancer Gene Ther 1:253.
26. Longo L, Christiansen H, Christiansen NM, Paulsen P, Cornaglia Ferraris P, Lampert F (1988) N-myc amplification at the chromosome band 1p32 in neuroblastoma cells as investigated by in-situ hybridization. J Cancer Res Clin Oncol 114:636
27. Martin RF, Beckwith JB (1968) Lymphoid infiltrates in neuroblastoma. Their occurrence and prognostic significance. J Pediatr Surg 3:727
28. Moss PAH, Rosenberg WMC, Bell JI (1992) The human T cell receptor in health and disease. Annu Rev Immunol 10:71
29. Nouri AME, Hussain RF, Oliver RTD, Handy AM, Bartkova I, Bodmer JD (1993) Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens. Eur J Cancer 29A:1895
30. Patel K, Moore SE, Dickson G, Rossel RJ., Beverley PC, Kemshead JT, Walsh FS (1989) Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma. Int J Cancer 44:573
31. Ponzoni M, Casalaro A, Lanciotti M, Montaldo PG, Cornaglia Ferraris P (1992) The combination of γ-interferon and tumour necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res 52:931
32. Prigione I, Facchetti P, Lanino E, Garaventa A, Pistoia V (1993) Clonal analysis of peripheral blood lymphocytes from three patients with advanced neuroblastoma receiving recombinant interleukin-2 and interferon α. Cancer Immunol Immunother 37:40
33. Rivoltini L, Arienti F, Orazi A, Cefalo G, Gasparini M, Gambacorti-Passerini C, Fossati Bellani F, Parmiani G (1992) Phenotypic and functional analysis of lymphocytes infiltrating pediatric tumours, with the characterization of the tumour phenotype. Cancer Immunol Immunother 34:241
34. Rolink AG, Melchers F, Palacios F (1989) Monoclonal antibodies reactive with the mouse interleukin 5 receptor. J Exp Med 169:1693
35. Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318
36. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, Simpson C, Carter C, Bock S, Schwartzentruber D, Wei J, White D (1988) Use of tumour infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 319:1676
37. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convi J, Modlin RL, Bloom T (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279
38. Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990) Human macrophage inflammatory protein a (MIP-1a) and MIP-1b attract distinct populations of lymphocytes. J Exp Med 177:1821
39. Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669
40. Smith KA (1993) Lowest dose interleukin-2 immunotherapy. Blood 81:1414
41. Somersalo K, Carpén O, Saksela E (1994) Stimulated natural killer cells secrete factors with chemotactic activity, including NAP-1/ IL8, which supports VLA-4 and VLA-5 mediated migration of T lymphocytes. Eur J Immunol 24:2957
42. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ (1993) Selective chemo-attraction of CD4 and CD8 subsets of human T cells by macrophage inflammatory protein-1 a and 1b. Science 60:355
43. Topalian SL, Muul LM, Soloman D, Rosenberg SA (1987) Expansion of human tumour infiltrating lymphocytes for use in immunotherapy trials. J Immunol Methods 102:127
44. Whiteside TL, Parmiani G (1994) Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol Immunother 39:15
45. Van der Bruggen P, Truversari C, Chomez P, Lurquin C, DePlaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643
46. + killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, antiCD3) depends on subclass specificity of target cell IgG FcR. J Immunol 138:3137
47. Vassalli P (1992) The pathophysiology of tumour necrosis factors. Annu Rev Immunol 10:411
48. Yamamura M, Uyemura K, Deans RJ, Weimberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277
49. Yang KD, Shao MF, Wang CL, Wu NC, Stone RM (1994) Neuroblastoma cell-mediated leukocyte chemotaxis: lineage-specific differentiation of interleukin-8 expression. Exp Cell Res 211:1
50. Zarcone D, Prasthofer E, Malavasi M, Pistoia V, Lo Buglio AF, Grossi CE (1987) Ultrastructural analysis of human natural killer cell activation. Blood 67:1454
51. Zlotnik A, Moore KW (1991) Interleukin-10. Cytokine 3:366